Article
Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.
PloS one - 1 Jan 2012
Yin Ji-Ye, Huang Qiong, Zhao Ying-Chun, Zhou Hong-Hao, Liu Zhao-Qian
Abstract excerpt
AIM: To determine the pharmacogenetics of platinum-based chemotherapy in Non Small Cell Lung Cancer (NSCLC) patients. METHODS: Publications were selected from PubMed, Cochrane Library and ISI Web of Knowledge. A meta-analysis was conducted to determine the association between genetic polymorphisms and platinum-based chemotherapy by checking odds ratio (OR) and 95% confidence interval (CI). RESULTS: Data were...
Topics
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung
- Humans
- Lung Neoplasms
- Pharmacogenetics
- Platinum
- Polymorphism, Single Nucleotide
- Prognosis
